These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 300541)

  • 61. Drug metabolites in renal failure: pharmacokinetic and clinical implications.
    Verbeeck RK; Branch RA; Wilkinson GR
    Clin Pharmacokinet; 1981; 6(5):329-45. PubMed ID: 7037261
    [No Abstract]   [Full Text] [Related]  

  • 62. A survey of pharmacokinetic data from pregnant women.
    Cummings AJ
    Clin Pharmacokinet; 1983; 8(4):344-54. PubMed ID: 6617042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations.
    Kanto JH
    Drugs; 1982 May; 23(5):354-80. PubMed ID: 6124415
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improved hypnotic treatment using chlormethiazole and temazepam.
    Briggs RS; Castleden CM; Kraft CA
    Br Med J; 1980 Mar; 280(6214):601-4. PubMed ID: 6102878
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Excretion of oxazepam in breast milk.
    Wretlind M
    Eur J Clin Pharmacol; 1987; 33(2):209-10. PubMed ID: 3691611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing.
    Lindholm A; Henricsson S; Lind M; Dahlqvist R
    Eur J Clin Pharmacol; 1988; 34(5):461-4. PubMed ID: 3203705
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical pharmacokinetics of non-opiate abused drugs.
    Busto U; Bendayan R; Sellers EM
    Clin Pharmacokinet; 1989 Jan; 16(1):1-26. PubMed ID: 2565176
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.
    Gaudreault P; Guay J; Thivierge RL; Verdy I
    Drug Saf; 1991; 6(4):247-65. PubMed ID: 1888441
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Individual differences in the disposition of drugs metabolised in the body.
    Alvan G
    Clin Pharmacokinet; 1978; 3(2):155-75. PubMed ID: 346288
    [No Abstract]   [Full Text] [Related]  

  • 70. Oxazepam disposition in uremic patients.
    Odar-Cederlöf I; Vessman J; Alván G; Sjöqvist F
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):52-62. PubMed ID: 300542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative bioavailability of oral dosage forms of oxazepam--correlation with in vitro dissolution rate.
    Pilbrant A; Glenne PO; Sundwall A; Vessman J; Wretlind M
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):7-15. PubMed ID: 322447
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
    Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
    Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical pharmacokinetics of oxazepam and lorazepam.
    Greenblatt DJ
    Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics of oxazepam in healthy volunteers.
    Alván G; Siwers B; Vessman J
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):40-51. PubMed ID: 300541
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.